Filing
Spy
Filing
Spy
Home
About
IDIX
Idenix Pharmaceuticals Inc
Biopharmaceutical company developing antiviral treatments
CUSIP: 45166R204
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2013 Q1
6 of 7 quarters
Total Value
$92.19M
Total Shares
26.04M
Net Share Change
+5.34M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Baupost Group LLC
$92.19M
26.04M
3.0%
ADD
+5.34M
(+25.8%)
Baupost Group LLC
$92.19M
26.04M shares
ADD
+5.34M
(+25.8%)
IDIX — Idenix Pharmaceuticals Inc - FilingSpy